Charter Oak Capital Management’s GSK GSK Stock Holding History

Charter Oak Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-142	Closed	-$8K	–	444
2022 Q2	$8K	Sell	142 -26	-15%	-$1.44K	﹤0.01%	621
2022 Q1	$9K	Buy	168 +2	+1%	+$109	﹤0.01%	640
2021 Q4	$9K	Buy	166 +1	+0.6%	+$52	﹤0.01%	624
2021 Q3	$8K	Buy	165 +2	+1%	+$100	﹤0.01%	604
2021 Q2	$8K	Sell	163 -19	-10%	-$913	﹤0.01%	604
2021 Q1	$8K	Buy	182 +50	+38%	+$2.27K	﹤0.01%	572
2020 Q4	$6K	Buy	+132	New	+$6.06K	﹤0.01%	572

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Charter Oak Capital Management's GSK Position: Q3 2022 in Review

Charter Oak Capital Management sold out of GSK (GSK) in Q3 2022, closing a stake of 142 shares — an estimated $8K sold.

Charter Oak Capital Management first reported a position in GSK in Q4 2020 and held it in 7 quarters. The position peaked at $9K in Q1 2022. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Charter Oak Capital Management reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Charter Oak Capital Management sold 142 GSK shares in Q3 2022, an estimated $8K.
Charter Oak Capital Management first reported a position in GSK in Q4 2020 and held it in 7 quarters.
Charter Oak Capital Management's GSK position peaked at $9K in Q1 2022.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.